World's Best Scientists 2026 revealed!
Mohamad Mohty

Mohamad Mohty

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 108 6026 5663 174 164 1105 40976

Mohamad Mohty publications per year

The chart shows the history of publications by Mohamad Mohty between 2000 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Mohamad Mohty published across 26 years, from 2000 to 2025, averaging 55 papers a year. Output peaked at 124 publications in 2020. 118 of the 1,431 publications appeared in the last two years.

No. of publications
25 50 75 100
Bar chart. Horizontal axis: year, 2000 to 2025. Vertical axis: number of publications, 0 to 124. Peak 124 publications in 2020. 2000: 2 publications 2001: 3 publications 2002: 6 publications 2003: 9 publications 2004: 12 publications 2005: 23 publications 2006: 11 publications 2007: 16 publications 2008: 28 publications 2009: 27 publications 2010: 40 publications 2011: 35 publications 2012: 49 publications 2013: 57 publications 2014: 70 publications 2015: 95 publications 2016: 91 publications 2017: 85 publications 2018: 101 publications 2019: 105 publications 2020: 124 publications 2021: 117 publications 2022: 106 publications 2023: 101 publications 2024: 85 publications 2025: 33 publications
2000 2025

1,431 publications in total across all disciplines

View publications per year as a table
Mohamad Mohty: publications per year, 2000 to 2025
Year Publications
2000 2
2001 3
2002 6
2003 9
2004 12
2005 23
2006 11
2007 16
2008 28
2009 27
2010 40
2011 35
2012 49
2013 57
2014 70
2015 95
2016 91
2017 85
2018 101
2019 105
2020 124
2021 117
2022 106
2023 101
2024 85
2025 33
Total 1,431
Download as CSV

Mohamad Mohty publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mohamad Mohty sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 1,101–1,120 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 1,105 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54 1,105
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Mohamad Mohty D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mohamad Mohty sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 108–109 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 108 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445 108
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Mohamad Mohty is a researcher affiliated with Inserm in France, primarily focused on the field of medicine with significant contributions to hematology. Their work spans a wide array of subfields including hematology, oncology, public health, molecular biology, and immunology.

The central themes in Mohty's research include hematopoietic stem cell transplantation and various hematological malignancies. Specific topics addressed in their publications cover:

  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Multiple Myeloma Research and Treatments
  • CAR-T Cell Therapy Research
  • Protein Degradation and Inhibitors
  • Polyomavirus and Related Diseases

Mohty has coauthored extensively with several frequent collaborators, indicating ongoing research partnerships. The most common coauthors include:

  • Arnon Nagler
  • Myriam Labopin
  • Fabio Ciceri
  • Didier Blaise
  • Éolia Brissot

In terms of publication venues, Mohty has appeared repeatedly in a number of specialized journals highlighting their research focus. Notable journals and the number of publications in each are:

  • Bone Marrow Transplantation (118 publications)
  • Blood (86 publications)
  • Transplantation and Cellular Therapy (22 publications)
  • American Journal of Hematology (19 publications)
  • Clinical Hematology International (18 publications)

Some of the recent papers associated with Mohamad Mohty's research portfolio include:

  • "Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease," 2020, published in New England Journal of Medicine
  • "Acute lymphoblastic leukaemia," 2020, published in The Lancet
  • "Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation," 2020, published in The Lancet Haematology
  • "Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results," 2023, published in Nature Medicine
  • "Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years," 2021, published in Bone Marrow Transplantation

Best Publications

  • Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

    Robert Zeiser;Nikolas von Bubnoff;Jason Butler;Mohamad Mohty

  • Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.

    Jean-Luc Harousseau;Michel Attal;Hervé Avet-Loiseau;Gerald Marit

  • Mechanisms of action of antithymocyte globulin : T-cell depletion and beyond

    M Mohty

  • Acute lymphoblastic leukaemia

    Florent Malard;Mohamad Mohty

  • The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

    Jan J. Cornelissen;Alois Gratwohl;Richard F. Schlenk;Jorge Sierra

  • Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories

    Régis Peffault de Latour;Jean Yves Mary;Célia Salanoubat;Louis Terriou

  • Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma

    Aurore Perrot;Valerie Lauwers-Cances;Jill Corre;Jill Corre;Nelly Robillard

  • Graft-Versus-Lymphoma Effect for Aggressive T-Cell Lymphomas in Adults: A Study by the Société Française de Greffe de Moëlle et de Thérapie Cellulaire

    Steven Le Gouill;Noel Milpied;Agnès Buzyn;Régis Peffault De Latour

  • Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

    T. Ruutu;A. Gratwohl;T. De Witte;B. Afanasyev

  • Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey

    Dietger Niederwieser;Helen Baldomero;Jeff Szer;Michael Gratwohl

  • Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis

    Salut Brunet;Myriam Labopin;Jordi Esteve;Jan Cornelissen

  • Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies.

    Reuben Benjamin;Reuben Benjamin;Charlotte Graham;Charlotte Graham;Deborah Yallop;Agnieszka Jozwik;Agnieszka Jozwik

  • Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019

    Rafael F. Duarte;Myriam Labopin;Peter Bader;Grzegorz W. Basak

  • Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP–EBMT analysis on patients with AML in remission

    A Ruggeri;M Labopin;F Ciceri;M Mohty

  • Reduced Intensity Conditioning Compared With Myeloablative Conditioning Using Unrelated Donor Transplants in Patients With Acute Myeloid Leukemia

    Olle Ringdén;Myriam Labopin;Gerhard Ehninger;Dietger Niederwieser

  • Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

    Celso A. Rodrigues;Guillermo Sanz;Claudio G. Brunstein;Jaime Sanz

  • CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT

    Martin Schmidt-Hieber;Myriam Labopin;Dietrich Beelen;Liisa Volin

Frequent Co-Authors

Myriam Labopin
Myriam Labopin Université Paris Cité
Arnon Nagler
Arnon Nagler Sheba Medical Center
Gérard Socié
Gérard Socié Université Paris Cité
Bipin N. Savani
Bipin N. Savani Vanderbilt University Medical Center
Ibrahim Yakoub-Agha
Ibrahim Yakoub-Agha University of Lille
Jan J. Cornelissen
Jan J. Cornelissen Erasmus University Rotterdam
Fabio Ciceri
Fabio Ciceri Vita-Salute San Raffaele University
Mauricette Michallet
Mauricette Michallet University of Helsinki
Nicolaus Kröger
Nicolaus Kröger Universität Hamburg
Christoph Schmid
Christoph Schmid University of Augsburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees online can open diverse career opportunities for students interested in medicine. For those aiming at leadership roles, affordable online mha programs offer flexibility and cost-effectiveness while preparing graduates for hospital and clinical management positions.

Advanced practitioners such as nurse leaders and educators can benefit from the cheapest online dnp programs, which focus on clinical excellence and healthcare innovation. Pharmacy is another in-demand field, and studying through a pharmacy degree online enables working professionals to advance without putting their careers on hold.

For those interested in health data, rhia certification programs online allow students to qualify for roles in medical information management and healthcare technology oversight. Each pathway offers distinctive benefits, affordability, and the convenience of online learning, making them appealing options for students charting their future in healthcare.

Best Scientists Citing Mohamad Mohty

Trending Scientists

Recently Published Articles